Your session is about to expire
← Back to Search
iPeer2Peer Mentorship for Inflammatory Bowel Disease
N/A
Waitlist Available
Led By Sara Ahola Kohut, PhD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; up to 12 weeks after baseline; 6 months post program
Awards & highlights
Study Summary
The iPeer2Peer program matches teens with Inflammatory Bowel Disease (IBD) with an older mentor who has learned to manage their IBD well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer program and those in the control group (no mentor).
Eligible Conditions
- Inflammatory Bowel Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline; up to 12 weeks after baseline; 6 months post program
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; up to 12 weeks after baseline; 6 months post program
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
TRANSITION-Q (measuring change)
Secondary outcome measures
Assessment of Quality if Life (AQoL-6D) (measuring change)
Brief Resiliency Scale (measuring change)
Chronic Disease Self-Efficacy scale (measuring change)
+10 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: iPeer2Peer MentorshipExperimental Treatment1 Intervention
10 sessions of 20-30 minute Skype video calls conducted over 5-12 weeks.
Group II: Waitlist Control GroupActive Control1 Intervention
The control group will receive standard care but without the iPeer2Peer program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iPeer2Peer program
2018
N/A
~150
Find a Location
Who is running the clinical trial?
The Hospital for Sick ChildrenLead Sponsor
686 Previous Clinical Trials
6,944,643 Total Patients Enrolled
Sara Ahola Kohut, PhDPrincipal InvestigatorThe Hospital for Sick Children
1 Previous Clinical Trials
6 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger